These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7998969)

  • 21. The calpastatin defect in hypertension is possibly due to a specific degradation by calpain.
    Salamino F; Sparatore B; De Tullio R; Pontremoli R; Melloni E; Pontremoli S
    Biochim Biophys Acta; 1991 Jun; 1096(4):265-9. PubMed ID: 2065100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and immunolocalization of the calpain-calpastatin system during parthenogenetic activation and fertilization in the rat egg.
    Haim K; Ben-Aharon I; Shalgi R
    Reproduction; 2006 Jan; 131(1):35-43. PubMed ID: 16388007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of calpains and calpastatin in human blood cells.
    Takano E; Park YH; Kitahara A; Yamagata Y; Kannagi R; Murachi T
    Biochem Int; 1988 Mar; 16(3):391-5. PubMed ID: 2838026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in intracellular localization of calpastatin during calpain activation.
    De Tullio R; Passalacqua M; Averna M; Salamino F; Melloni E; Pontremoli S
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):467-72. PubMed ID: 10510315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calpastatin overexpression attenuates amyloid-beta-peptide toxicity in differentiated PC12 cells.
    Vaisid T; Barnoy S; Kosower NS
    Neuroscience; 2008 Oct; 156(4):921-31. PubMed ID: 18786620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and some properties of human erythrocyte calpastatin.
    Takano E; Murachi T
    J Biochem; 1982 Dec; 92(6):2021-8. PubMed ID: 6897650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The non-lysosomal, calcium-dependent proteolytic system of mammalian cells.
    Mellgren RL; Renno WM; Lane RD
    Revis Biol Celular; 1989; 20():139-59. PubMed ID: 2561539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and some properties of calpain II (high-Ca2+-requiring form of calpain) in carp (Cyprinus carpio) erythrocytes.
    Toyohara H; Makinodan Y; Ikeda S
    Comp Biochem Physiol B; 1985; 81(3):583-6. PubMed ID: 2992873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells.
    Murray SS; Grisanti MS; Bentley GV; Kahn AJ; Urist MR; Murray EJ
    Exp Cell Res; 1997 Jun; 233(2):297-309. PubMed ID: 9194492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The calpain-calpastatin system in mammalian cells: properties and possible functions.
    Melloni E; Salamino F; Sparatore B
    Biochimie; 1992 Mar; 74(3):217-23. PubMed ID: 1610935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid beta peptide toxicity in differentiated PC12 cells: calpain-calpastatin, caspase, and membrane damage.
    Vaisid T; Kosower NS; Elkind E; Barnoy S
    J Neurosci Res; 2008 Aug; 86(10):2314-25. PubMed ID: 18438916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in calpastatin localization and expression during calpain activation: a new mechanism for the regulation of intracellular Ca(2+)-dependent proteolysis.
    Averna M; De Tullio R; Capini P; Salamino F; Pontremoli S; Melloni E
    Cell Mol Life Sci; 2003 Dec; 60(12):2669-78. PubMed ID: 14685690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of erythrocyte calpain and calpastatin activities in beta 0-thalassemia/Hb E disease.
    Macotpet G; Wilairat P; Fucharoen S; Wasi P
    Birth Defects Orig Artic Ser; 1987; 23(5A):257-61. PubMed ID: 2825832
    [No Abstract]   [Full Text] [Related]  

  • 34. Factors influencing the binding of calpain I to human erythrocyte inside-out vesicles.
    Lee WJ; Adachi Y; Maki M; Hatanaka M; Murachi T
    Biochem Int; 1990 Oct; 22(1):163-71. PubMed ID: 2282076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the mechanism of binding of calpastatin, the protein inhibitor of calpains, to biologic membranes.
    Mellgren RL
    Biochem Biophys Res Commun; 1988 Jan; 150(1):170-6. PubMed ID: 2827664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The calpain-calpastatin system in hematopoietic cells.
    Murachi T; Murakami T; Ueda M; Fukui I; Hamakubo T; Adachi Y; Hatanaka M
    Adv Exp Med Biol; 1989; 255():445-54. PubMed ID: 2559604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calpain II activity and calpastatin content in brain regions of 3- and 24-month-old rats.
    Kenessey A; Banay-Schwartz M; DeGuzman T; Lajtha A
    Neurochem Res; 1990 Mar; 15(3):243-9. PubMed ID: 2366929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of a new component of the Ca(2+)-dependent proteolytic system in rat brain: the calpain activator.
    Melloni E; Michetti M; Salamino F; Sparatore B; Pontremoli S
    Biochem Biophys Res Commun; 1998 Aug; 249(3):583-8. PubMed ID: 9731179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragmentation of a 70000-dalton calpastatin molecule upon its complex formation with calpain.
    Shigeta K; Yumoto N; Murachi T
    Biochem Int; 1984 Sep; 9(3):327-33. PubMed ID: 6095848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.